Gray Susannahinsider trades
In SEC Form 4 filings, Gray Susannah is listed as Director of Theravance Biopharma, Inc. (TBPH). Gray Susannah reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 24.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | Director | 7 | Sep 24 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 42,137 | not reported | not reported | 6,009 | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D | 6,009 | not reported | not reported | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 32,666 | $9.87 | $322,413 | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 22,044 | $10.95 | $241,382 | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 23,576 | $9.49 | $223,736 | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 24,258 | $9.39 | $227,783 | not reported | No | Form 4 |
| TBPHTheravance Biopharma, Inc. | Sep 23 | Sep 24 | D · derivative | 13,398 | $16.64 | $222,943 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.